Meet Max Allewijn

Max Allewijn

The goal of this system is to be able to gather lots of data in the transcriptome, and later the proteome, under many different conditions. This can range from different ratios of polymerases and sigma factors, to changing the locations of genes on a chromosome, to even comparing a bare-bones in-vitro transcription system to a lysate.

Hi, my name is Max Allewijn. I studied Molecular Lifesciences in Wageningen, where I was part of the 2022 iGEM team “Colourectal”. I have done my internship at LenioBio in Aachen, working to improve their cell-free expression platform, and spent the last 1,5 years working at the RIVM coordinating the genomic surveillance of carbapenem-resistant Acinetobacter baumannii for the Netherlands.

As PhD in the EVOLF consortium I will be working with Prof. Dr. Wilhelm Huck at the Radboud University to develop a robust method for high-throughput in-vitro transcriptomics. Thanks to the work of my predecessor Leonardo we’re already a good ways there, so to me falls the task to further improve and refine our methods. The goal of this system is to be able to gather lots of data in the transcriptome, and later the proteome, under many different conditions. This can range from different ratios of polymerases and sigma factors, to changing the locations of genes on a chromosome, to even comparing a bare-bones in-vitro transcription system to a lysate. Hopefully, this will become a very useful tool for other groups in EVOLF to learn more about their designed systems.